Time: Sharing groups at 7pm and speaker at 8pm
Classroom 3 &4 (Lower Level) Proctor Professional Bldg.
Speaker: Sharon Windsor, Registered Dietitian, Cancer Center
For Healthy Living
Topic: Nutrition. Focusing on cancer prevention guidelines.
If you would like to receive this newsletter via e-mail, please e-mail firstname.lastname@example.org. By doing so, you help us to control our costs that are incurred through postal mail.
Ms. Sara Campbell, RN, BSN, OCN works with Sanifi Oncology. She spoke to our group about advanced metastatic prostate cancer. Before joining the pharmaceutical company, Sara was an oncology nurse for 15 years. She is also a breast cancer survivor.
She travels around the country educating nurses, doctors, pharmacists and advocacy groups like Us TOO International and its chapters.
Prostate cancer is the #1 occurring cancer among American males and accounts for 28% of all cancers in males. It is the #2 cause of death among males, with lung cancer being in the #1 position. Some 200,000 men will be diagnosed each year with prostate cancer.
In the last year and a half, 4 new drugs have been approved to treat advanced prostate cancer and she expects that 1 to 2 more will get FDA approval in the next year.
Prostate cancer can spread through the blood stream and can also spread to the bone, lungs and liver. Sara spoke to us about drugs that would be administered after a drug like Lupron had run its course. Most of us have heard of Provenge which was recently approved for treatment of advanced prostate cancer which involves removing white blood cells and these are shipped to a facility which mixes a protein to them. This mixture is then given back to the patient. This process is done 3 times and allows the body to recognize cancer cells and can attack them. It extends the overall survival time about 4 months. Side effects are similar to having the flu.
She mentioned a website that one can log onto in order to get cancer guidelines which can help a patient address their own particular cancer. This is the National Comprehensive Cancer Network at www.nccn.org.
Sara gave excellent information to us and we look forward to having her speak to our group next year.
Speakers who will address our group later this year include:
Dr. Michael Veeder, July 24